Stocks Under $10: Boston Scientific (BSX)

Richard Suttmeier |

BSXBoston Scientific (BSX) – ($9.08) has a Buy rating according to ValuEngine with fair value at $9.66, which makes the stock 6.00% undervalued. The one-year price target is $9.52. ValuEngine Profile – “Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.”

Analysis – The daily chart for BSX shows overbought momentum with the stock above its 21-day, 50-day and 200-day simple moving averages at $8.37, $7.88 and $6.51. My weekly value level is $8.55 with no risky levels.



Courtesy of Thomson / Reuters

Ticker

Company Name

Mkt Price

Fair Value

One-Year Price Target

Last 12-Mon Retn (%)

5-Yr Avg Retn (%)

P/E Ratio

BSX

BOSTON SCIENTIFIC

9.08

9.66

9.52

53.64

-11.15

13.22

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
BSX Boston Scientific Corporation 20.61 0.00 0.00 8,718,620
PRNAF Prana Biotechnology Ltd 0.04 0.00 0.00 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…